Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

3.0K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
3.0K
Transduction01:16

Transduction

3.0K
Among the three main modes of HGT—transformation, conjugation, and transduction—transduction is unique in that it is mediated by bacteriophages, or bacterial viruses.Transduction occurs in two ways. Generalized transduction occurs during the lytic cycle of a bacteriophage infection. In this process, bacteriophages infect bacterial cells, replicate within them, and ultimately cause cell lysis, releasing newly assembled virions. Occasionally, random fragments of the bacterial genome...
3.0K
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

2.0K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
2.0K
Colonisation of Pathogens01:25

Colonisation of Pathogens

77
Pathogen colonization of host tissues is a critical step in the development of infectious diseases. Various pathogenic microorganisms, including bacteria, fungi, viruses, and protozoa, have evolved complex strategies to attach to, invade, and persist within host environments. These mechanisms enable pathogens to establish infections, evade immune responses, and resist antimicrobial treatments.Attachment to Host CellsIn bacteria, colonization typically begins with adherence to host epithelial...
77
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

219
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
219
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

90
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
90

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Targeting Microbial Bile Salt Hydrolase Reprograms Bile Acid Metabolism and Ameliorates Metabolic Dysfunction-Associated Steatohepatitis in Mice.

bioRxiv : the preprint server for biology·2026
Same author

Subtype Differences in Major Adverse Liver Outcomes and Cardiovascular Events and Mortality in Steatotic Liver Disease: A UK Biobank Analysis.

Alimentary pharmacology & therapeutics·2026
Same author

Covert hepatic encephalopathy as a multi-organ syndrome: the gut-liver-muscle-brain axis, diagnosis, treatment, and multidisciplinary care.

Journal of gastroenterology·2026
Same author

Faecal Cathepsin B and S Are Associated With Liver Disease Severity and Adiposity in MASLD.

Liver international : official journal of the International Association for the Study of the Liver·2026
Same author

Lactic acid bacteria and endogenous ethanol mediate proton pump inhibitor-associated MASLD: a multicohort cross-sectional mediation analysis.

Gut microbes·2026
Same author

Reply to: "Hepatic CTSB is Kupffer cell-enriched, whereas disease-state stratification is more strongly captured by endotoxin/TLR4 programmes".

Journal of hepatology·2026

関連する実験動画

Updated: May 5, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

16.2K

バンコマイシン耐性腸球菌は,抗生物質によって引き起こされた先天性免疫不全を悪用しています.

Katharina Brandl1, George Plitas, Coralia N Mihu

  • 1Infectious Diseases Service, Department of Medicine, Immunology Program, Sloan-Kettering Institute, New York, New York, USA.

Nature
|August 30, 2008
PubMed
まとめ

ブロードスペクトル抗生物質は,重要な免疫タンパク質であるRegIIIgammaを減少させ,危険なVRE感染を可能にします. Toll型受容体刺激によるRegIIIgammaの回復は,抗生物質耐性細菌と戦う方法を提供します.

さらに関連する動画

The Nematode Caenorhabditis Elegans - A Versatile In Vivo Model to Study Host-microbe Interactions
11:58

The Nematode Caenorhabditis Elegans - A Versatile In Vivo Model to Study Host-microbe Interactions

Published on: October 18, 2017

8.9K
Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates
08:32

Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates

Published on: February 17, 2023

1.7K

関連する実験動画

Last Updated: May 5, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

16.2K
The Nematode Caenorhabditis Elegans - A Versatile In Vivo Model to Study Host-microbe Interactions
11:58

The Nematode Caenorhabditis Elegans - A Versatile In Vivo Model to Study Host-microbe Interactions

Published on: October 18, 2017

8.9K
Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates
08:32

Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates

Published on: February 17, 2023

1.7K

科学分野:

  • 微生物学 微生物学とは
  • 免疫学 免疫学とは
  • 胃腸内科 胃腸内科

背景:

  • バンコミシン耐性腸球菌 (VRE) のような抗生物質耐性細菌感染症は,医療における大きな課題です.
  • 抗生物質の使用がこれらの感染症を促進するメカニズムは,完全に理解されていません.

研究 の 目的:

  • 抗生物質治療が抗生物質耐性細菌に対する腸内免疫防御に与える影響を調査する.
  • 抗生物質療法とVREに対する感受性の増加を結びつける分子メカニズムを特定する.

主な方法:

  • 腸内遺伝子発現の変化を評価するためにマウスの抗生物質治療.
  • 腸内におけるバンコミシン耐性腸内細菌 (VRE) のコロニー化の定量化.
  • 免疫反応を評価するために,リポポリサッカリド (LPS) でトール型受容体4 (TLR4) の刺激.

主要な成果:

  • 抗生物質療法によりマウスの腸内レギIIIガマ (Reg3g) 発現が著しく低下しました.
  • 減少したRegIIIgammaレベルは,VREコロニー化の増加と相関しています.
  • 口服によるリポポリサッカリド (LPS) の投与により,RegIIIガマの発現が回復し,VRE.ウイルスに対する耐性が強化されました.

結論:

  • RegIIIgammaの抗生物質誘発抑制は,VRE.のようなグラム陽性病原体に対する先天性粘膜免疫を損なう.
  • トール型受容体をターゲットにすることは,粘膜の防御を回復し,抗生物質耐性感染症と闘うための潜在的な戦略です.